Dicerna Pharmaceuticals Logo

Email this page: News Release

Dicerna Pharmaceuticals Presents Positive Preclinical Data on its DsiRNA Therapeutics Targeting MYC and β-Catenin at AACR MYC: From Biology to Therapy Meeting

For security reasons, registration is required before you can use this feature.
* Indicates required field